The FDA has accepted the supplemental new drug application (sNDA) from Arcutis Biotherapeutics, Inc. for roflumilast cream 0.15% for the treatment of atopic dermatitis (AD) in adults and children down to age 6. The FDA assigned the application a Prescription Drug User...
Day in and day out, dermatology care professionals face multiple decisions, record pages of medical data, and counsel patients on product selection and use. So what are the best ways to do these various tasks. Dermatology thought leaders share their recommendations in...
By Joe Gorelick, MSN, FNP-C The ability to treat food allergy with oral immunotherapy could be closer to clinical reality. The FDA has granted Fast Track Designation for ADP101, an investigational multi-food oral immunotherapy (mOIT) from Alladapt Immunotherapeutics,...
As the field of biologic and small molecule therapies has taken shape and grown in the last two decades, so has the role of the Biologic Coordinator or Access Specialist. Across multiple medical specialties, Biologic Coordinators fill an administrative role in the...
Kristine Kucera, PA-C, MPAS, DHS Atopic dermatitis is more prevalent in African American (19.3%), compared with European American children. Yet, challenges in diagnosing and treating atopic dermatitis in individuals with skin of color persist. These challenges...
Kristine Kucera, PA-C, MPAS, DHS The World Health Organization declared October 10 Mental Health Day. With this, they acknowledged the hidden burdens of skin disease. A large survey focused on patients suffering from dermatological conditions showed that mental...